Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
株式のランク #15300
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
株価
$6.64
最終同期: 2026-08-31
時価総額
$361.08M
変化(1日)
-0.82%
変化(1年)
-61.27%
US
取引 Upstream Bio, Inc. (UPB)

カテゴリー

Upstream Bio, Inc.(UPB)の配当利回りの履歴
Upstream Bio, Inc.(銘柄コード: UPB)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Upstream Bio, Inc.(UPB)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)